Skip to content

Stock-Based Comp at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$22.38M+70.4%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$4.46M-51.5%
iRadimed logo
iRadimedIRMD
$684K-17.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$15.85M-8.8%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$6.6M+408%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$1.7M-6.4%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's stock-based comp?
Rapid Micro Biosystems (RPID) reported stock-based comp of $1.22M in Q1 2026.
How has Rapid Micro Biosystems's stock-based comp changed year-over-year?
Rapid Micro Biosystems's stock-based comp increased by 17.4% year-over-year, from $1.04M to $1.22M.
What is the long-term trend for Rapid Micro Biosystems's stock-based comp?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's stock-based comp has grown at a 21.6% compound annual growth rate (CAGR), from $1.84M to $4.03M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.